{"entity":{"id":"nct04440735","kind":"trial","name":"A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of Atezolizumab in non-small-cell lung cancer and small-cell lung cancer, run by Kahr Medical, active and no longer recruiting.","summary":"A Study of DSP107 Alone and in Combination with Atezolizumab for Patients with Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT04440735 by Kahr Medical, with 125 participants planned, started 2020-10-07 and due to reach its primary completion in 2025-09. Interventions recorded: DSP107, Atezolizumab. Conditions listed: Advanced Solid Tumor, Non Small Cell Lung Cancer, Colorectal Cancer. No results are recorded here; the registry entry is the source.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT04440735","url":"https://clinicaltrials.gov/study/NCT04440735"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc","sclc","colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":["atezolizumab"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT04440735","phase":"1/2","setting":"A First-in-Human, Two-Part, Open-Label, Phase I/II Study of DSP107 in Subjects with Advanced Solid Tumors Including a Dose-escalation Safety Study (part 1) and Preliminary Efficacy Assessment of DSP107 As Monotherapy and in Combination with Atezolizumab (part 2)","sponsor":"Kahr Medical","enrolled":125,"outcomes":[]},"route":"/trials/nct04440735/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"},{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"atezolizumab","kind":"drug","name":"Atezolizumab","route":"/drugs/atezolizumab/"}]}}